ALZNVSSLS• 7 Days (Normalized)
ALZN vs SLS (Alzamend Neuro Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 09 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ALZN Performance $1.84
+9.29%
Alzamend Neuro Inc.
Normalized Baseline0.00%
SLS Performance $11.53
-17.35%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ALZN LEADS
+26.64%
ALZN outperforming by 26.64%
ALZNSLS
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ALZN SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | ALZN Price | ALZN Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.84 | +9.29% | $11.53 | -17.35% | +26.64% |
| Sep 15, 2026 | $1.78 | +5.95% | $11.29 | -19.07% | +25.02% |
| Sep 14, 2026 | $1.75 | +4.17% | $11.73 | -15.91% | +20.08% |
| Sep 11, 2026 | $1.72 | +2.38% | $11.55 | -17.20% | +19.58% |
| Sep 10, 2026 | $1.70 | +1.19% | $13.49 | -3.30% | +4.49% |
| Sep 09, 2026 | $1.68 | +0.00% | $13.95 | +0.00% | +0.00% |